Citius Oncology, Inc. CTOR Capital Contribution Of Due To Related Party By Parent

Capital Contribution Of Due To Related Party By Parent at other companies

ChewyCHWY

$0—

Lithium AmericasLAC

$25M—

Resolute Holdings Management RHLD

$11.9M—

Jerash Holdings (US), Inc.JRSH

$1.9M0.0%

Bowhead Specialty HoldingsBOW

$0—

TKO Group HoldingsTKO

$1K-99.9%

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Operating cash flow-$3.8M-179%

Market cap$60.45M-74.7%

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:CapitalContributionOfDueToRelatedPartyByParent.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Citius Oncology, Inc.'s capital contribution of due to related party by parent?: Citius Oncology, Inc. (CTOR) reported capital contribution of due to related party by parent of $8.3M in Q3 2024.
What does capital contribution of due to related party by parent mean?: Indicates the conversion of liabilities owed to related parties into equity or capital contributions. This reflects the financial support provided by parent entities or affiliates to strengthen the company's balance sheet without immediate cash settlement.